REVELUTION-2: Relugolix+Abiraterone Acetate (AA) Versus Leuprolide+AA Cardiac Trial

Clinical trial NCT06650579 · RECRUITING

Trial details

NCT number: NCT06650579
Sponsor: Emory University
Status: RECRUITING
Phase: Phase 3
Study type: INTERVENTIONAL

Recurrent Prostate Carcinoma Stage III Prostate Cancer AJCC v8 Stage IVA Prostate Cancer AJCC v8

Start date: 2025-01-31
Primary completion: 2029-07-01
Enrollment: 72

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.